אמריל 2 מג ישראל - עברית - Ministry of Health

אמריל 2 מג

sanofi israel ltd - glimepiride - טבליה - glimepiride 2 mg - glimepiride - glimepiride - non-insulin-dependent diabetes melitus ( adult-onset diabetes, type ii diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels.

אמריל 3 מג ישראל - עברית - Ministry of Health

אמריל 3 מג

sanofi israel ltd - glimepiride - טבליה - glimepiride 3 mg - glimepiride - glimepiride - non-insulin-dependent diabetes melitus ( adult-onset diabetes, type ii diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels.

אמריל 4 מג ישראל - עברית - Ministry of Health

אמריל 4 מג

sanofi israel ltd - glimepiride - טבליה - glimepiride 4 mg - glimepiride - glimepiride - non-insulin-dependent diabetes melitus ( adult-onset diabetes, type ii diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels.

קומדין 1 מג ישראל - עברית - Ministry of Health

קומדין 1 מג

taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 1 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

קומדין 2 מג ישראל - עברית - Ministry of Health

קומדין 2 מג

taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 2 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonar embolism. coumadin is indicated for the prophylaxis and/or treatment of the tromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

קומדין 2.5 מג ישראל - עברית - Ministry of Health

קומדין 2.5 מג

taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 2.5 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

קומדין 3 מג ישראל - עברית - Ministry of Health

קומדין 3 מג

taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 3 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

קומדין 4 מג ישראל - עברית - Ministry of Health

קומדין 4 מג

taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 4 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

קומדין 5 מג ישראל - עברית - Ministry of Health

קומדין 5 מג

taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 5 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonar embolis. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

קומדין 6 מג ישראל - עברית - Ministry of Health

קומדין 6 מג

taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 6 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonar embolis. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.